Regulatory and other responses to the pharmaceutical opioid problem
- PMID: 31389014
- DOI: 10.5694/mja2.50303
Regulatory and other responses to the pharmaceutical opioid problem
Keywords: Analgesics, opioid; Codeine; Pharmacogenomics.
Comment on
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Jan;210(1):6-8.e1. doi: 10.5694/mja2.12047. Epub 2018 Dec 12. Med J Aust. 2019. PMID: 30636303 Free PMC article. No abstract available.
-
Regulatory and other responses to the pharmaceutical opioid problem.Med J Aust. 2019 Sep;211(5):237-237.e1. doi: 10.5694/mja2.50297. Epub 2019 Aug 6. Med J Aust. 2019. PMID: 31389024 No abstract available.
References
-
- Campbell G, Lintzeris N, Gisev N, et al. Regulatory and other responses to the pharmaceutical opioid problem. Med J Aust 2019; 210: 6-8. https://www.mja.com.au/journal/2019/210/1/regulatory-and-other-responses...
-
- Ting S, Schug S. The pharmacogenomics of pain management: prospects for personalized medicine. J Pain Res 2016; 9: 49-56.
-
- Royal College of Pathologists of Australia. Position statement: utilisation of pharmacogenetics in healthcare. Sydney: RCPA, 2018. http://www.rcpa.edu.au/Library/College-Policies/Position-Statements/Util... (viewed July 2019).
-
- Comer SD, Dworkin RH, Strain EC. Medical devices to prevent opioid use disorder: innovative approaches to addressing the opioid crisis. JAMA 2019. https://doi.org/10.1001/jamapsychiatry.2018.4379. [Epub ahead of print]
-
- Significant decrease in the amount of codeine supplied to Australians - TGA data analysis. Canberra: Therapeutic Goods Administration, 2019. https://www.tga.gov.au/media-release/significant-decrease-amount-codeine... (viewed July 2019).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
